Tor Olofsson

4.4k total citations
145 papers, 3.3k citations indexed

About

Tor Olofsson is a scholar working on Hematology, Immunology and Rheumatology. According to data from OpenAlex, Tor Olofsson has authored 145 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Hematology, 44 papers in Immunology and 37 papers in Rheumatology. Recurrent topics in Tor Olofsson's work include Acute Myeloid Leukemia Research (33 papers), Rheumatoid Arthritis Research and Therapies (21 papers) and Spondyloarthritis Studies and Treatments (20 papers). Tor Olofsson is often cited by papers focused on Acute Myeloid Leukemia Research (33 papers), Rheumatoid Arthritis Research and Therapies (21 papers) and Spondyloarthritis Studies and Treatments (20 papers). Tor Olofsson collaborates with scholars based in Sweden, Denmark and United States. Tor Olofsson's co-authors include Inge Olsson, Bengt Sallerfors, Håkan Odeberg, Ingemar Winqvist, Urban Gullberg, Per Venge, Anders Tunek, Thoas Fioretos, Stig Lenhoff and Carin Lassen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Tor Olofsson

144 papers receiving 3.2k citations

Peers

Countries citing papers authored by Tor Olofsson

Since Specialization

Citations

This map shows the geographic impact of Tor Olofsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tor Olofsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tor Olofsson more than expected).

Fields of papers citing papers by Tor Olofsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tor Olofsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tor Olofsson. The network helps show where Tor Olofsson may publish in the future.

Co-authorship network of co-authors of Tor Olofsson

This figure shows the co-authorship network connecting the top 25 collaborators of Tor Olofsson. A scholar is included among the top collaborators of Tor Olofsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tor Olofsson. Tor Olofsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effectiveness of JAK Inhibitors Compared With Biologic Disease‐Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study 2024 ·Arthritis & Rheumatology ·(unknown), Daniela Di Giuseppe, Johan Askling, Stefan Bergman, Hannah Bower, Katerina Chatzidionysiou, Helena Forsblad‐d’Elia, Alf Kastbom, Tor Olofsson, Thomas Frisell, Carl Turesson	2
2	Cost-effectiveness analysis of bimekizumab for the treatment of active psoriatic arthritis in Sweden 2023 ·Journal of Medical Economics ·Valgerður Sigurðardóttir, (unknown), (unknown), Tor Olofsson, (unknown), Susannah Sadler, (unknown), (unknown), (unknown)	2
3	Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis: A Decision Tree Analysis by Indication 2023 ·Advances in Therapy ·Johan Dalén, Axel Svedbom, E Hernlund, Tor Olofsson, Christopher M. Black	3
4	Persistent pain and its predictors after starting anti-tumour necrosis factor therapy in psoriatic arthritis: what is the role of inflammation control? 2023 ·Scandinavian Journal of Rheumatology ·(unknown), Johan K. Wallman, Anna Jöud, Maria E. C. Schelin, (unknown), Elisabet Lindqvist, Jon Lampa, Meliha C Kapetanovic, Tor Olofsson	4
5	Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study 2023 ·RMD Open ·Ulf Lindström, Daniela Di Giuseppe, Sofia Exarchou, Gerd-Marie Alenius, Tor Olofsson, Eva Klingberg, L. Jacobsson, Johan Askling, Johan K. Wallman	8
6	How good is the agreement between clinical diagnoses and classification criteria fulfilment in axial spondyloarthritis? Results from the SPARTAKUS cohort 2022 ·Scandinavian Journal of Rheumatology ·Elisabet Lindqvist, Tor Olofsson, Anna Jöud, Mats Geijer, Johan K. Wallman, (unknown)	3
7	Elevated fecal levels of the inflammatory biomarker calprotectin in early systemic sclerosis 2022 ·Rheumatology International ·(unknown), Johan K. Wallman, (unknown), Elisabet Lindqvist, Tor Olofsson, Kristofer Andréasson	5
8	Sustained Remission in Patients With Rheumatoid Arthritis Receiving Triple Therapy Compared to Biologic Therapy: A Swedish Nationwide Register Study 2021 ·Arthritis & Rheumatology ·(unknown), (unknown), Jan‐Åke Nilsson, Tor Olofsson, Tore Saxne, Pierre Geborek, Meliha C Kapetanovic	3
9	Chronic Pain and Assessment of Pain Sensitivity in Patients With Axial Spondyloarthritis: Results From the SPARTAKUS Cohort 2020 ·The Journal of Rheumatology ·(unknown), Tor Olofsson, Stefan Bergman, Ann Bremander, Lars Erik Kristensen, (unknown), Johan K. Wallman, Elisabet Lindqvist	21
10	Analysis of the DNA methylome and transcriptome in granulopoiesis reveals timed changes and dynamic enhancer methylation 2014 ·Blood ·Michelle Rönnerblad, Robin Andersson, Tor Olofsson, Iyadh Douagi, Mohsen Karimi, Sylvain Lehmann, Ilka Hoof, Michiel de Hoon, Masayoshi Itoh, Sayaka Nagao-Sato, Hideya Kawaji, Timo Lassmann, Piero Carninci, Yoshihide Hayashizaki, Alistair R. R. Forrest, Albin Sandelin, Karl Ekwall, Peter Arner, Andreas Lennartsson	60
11	Leukemia associated mutant Wilms’ tumor gene 1 protein promotes expansion of human hematopoietic progenitor cells 2013 ·Leukemia Research ·(unknown), (unknown), (unknown), Andreas Lennartsson, Tor Olofsson, Björn Nilsson, Urban Gullberg	6
12	The Radical-Binding Lipocalin A1M Binds to a Complex I Subunit and Protects Mitochondrial Structure and Function 2012 ·Antioxidants and Redox Signaling ·Magnus Olsson, (unknown), Heike Kotarsky, Tor Olofsson, Tomas Leanderson, Matthias Mörgelin, Vineta Fellman, Bo Åkerström	39
13	Gene expression signatures in childhood acute leukemias are largely unique and distinct from those of normal tissues and other malignancies 2010 ·BMC Medical Genomics ·Anna Andersson, Patrik Edén, Tor Olofsson, Thoas Fioretos	25
14	Real-Time PCR Analysis for Blood Cell Lineage Specific Markers 2009 ·Methods in molecular biology ·(unknown), Tor Olofsson	4
15	Characterisation of genomic translocation breakpoints and identification of an alternative TCF3/PBX1 fusion transcript in t(1;19)(q23;p13)‐positive acute lymphoblastic leukaemias 2007 ·British Journal of Haematology ·Kajsa Paulsson, Tord Jonson, Ingrid Øra, Tor Olofsson, Ioannis Panagopoulos, Bertil Johansson	17
16	Fusion of ETV6 with an intronic sequence of the BAZ2A gene in a paediatric pre‐B acute lymphoblastic leukaemia with a cryptic chromosome 12 rearrangement 2006 ·British Journal of Haematology ·Ioannis Panagopoulos, Bodil Strömbeck, Margareth Isaksson, Jesper Heldrup, Tor Olofsson, Bertil Johansson	18
17	Molecular signatures in childhood acute leukemia and their correlations to expression patterns in normal hematopoietic subpopulations 2005 ·Proceedings of the National Academy of Sciences ·Anna Andersson, Tor Olofsson, David Lindgren, Björn Nilsson, (unknown), Patrik Edén, Carin Lassen, Johan Råde, Magnus Fontes, Helena Mörse, Jesper Heldrup, Mikael Behrendtz, Felix Mitelman, Mattias Höglund, Bertil Johansson, Thoas Fioretos	78
18	Presence of clonal cells in all stem cell enriched grafts in transplanted multiple myeloma. 1997 ·Blood ·Ulf Thunberg, (unknown), Britt Thuresson, Jan Westin, Agneta Swedin, Stig Lenhoff, Tor Olofsson, Geisler Ch, Peter Gimsing, Niels Smedegaard Andersen, (unknown), (unknown), Mats Bengtsson, Johan Sällström, Bengt Simonsson, Kjell Carlsson	1
19	Bernard‐Soulier syndrome Karlstad: Trp 498→Stop mutation resulting in a truncated glycoprotein Ibα that contains part of the transmembranous domain 1997 ·British Journal of Haematology ·Lars Holmberg, Diana Karpman, (unknown), Tor Olofsson	19
20	Clonal CD5-positive B lymphocytes in myelodysplastic syndrome with systemic vasculitis and trisomy 8 1997 ·Annals of Hematology ·Rolf Billström, Bertil Johansson, Bodil Strömbeck, Wael El‐Rifai, Marcelo L. Larramendy, Tor Olofsson, Felix Mitelman, Sakari Knuutila	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact